Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00276900 · ClinicalTrials.gov registry record · Phase 3
Sertraline for the Prevention of Recurrent Postpartum Depression
A Phase 3 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
NCT00276900 is a Phase 3 study that has completed, run by University of Pittsburgh. The registered enrollment target is 300 participants.
The verdict
NCT00276900, a Phase 3 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of taking sertraline within 24 hours of giving birth in preventing a recurrence of postpartum depression.
Interventions
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2003-12 |
| Est. Completion | 2006-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00276900
The ClinicalTrials.gov registry entry for NCT00276900 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sertraline is the first listed.
NCT00276900 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00276900 about?
NCT00276900 is a clinical study titled "Sertraline for the Prevention of Recurrent Postpartum Depression". This study will determine the effectiveness of taking sertraline within 24 hours of giving birth in preventing a recurrence of postpartum depression.
What is the current status of trial NCT00276900?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2003-12. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00276900?
The interventions under investigation include: Sertraline (DRUG).
Who is sponsoring clinical trial NCT00276900?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.